Search results for " and Jellies"

showing 2 items of 2 documents

Impact of a new carrageenan-based vaginal microbicide in a female population with genital HPV-infection: First experimental results

2019

OBJECTIVE: The objective of this study was to assess safety, satisfaction, and anti- viral effect of a new carrageenan-based vaginal microbicide in a population of fertile female patients with genital human papillomavirus (HPV) infection. PATIENTS AND METHODS: Forty healthy and sexually active women aged 18-45 years with genital HPV infection were enrolled. Each subject was treated with a gel formulated with 0.02% carrageenan and Propionibacterium extract (CGP) (Carvir, Depofarma SpA, Mogliano Veneto, Treviso, Italy). The subjects were evaluated at baseline, after the I cycle of therapy and after the II cycle. At final status, treatment acceptability and satisfaction were evaluated using a …

AdultSettore MED/07 - Microbiologia E Microbiologia ClinicaHPVAdolescentSocio-culturaleMicrobicideCarrageenanCarrageenan Papillomavirus Microbicide Female population HPV.Young AdultAnti-Infective AgentsChondrusHumansProspective StudiesCarrageenan Papillomavirus Microbicide Female population HPVPapillomaviridaeFemale populationPapillomavirus InfectionsMiddle AgedPapillomavirusSeaweedAdministration IntravaginalTreatment OutcomeColposcopyPatient SatisfactionCase-Control StudiesDNA ViralVaginaVaginal Creams Foams and JelliesFemaleFollow-Up Studies
researchProduct

Efficacy and tolerability of a plant-based, multi-component cream (Ginetrox®) in vulvovaginal disorders of the genitourinary syndrome during menopaus…

2017

BACKGROUND Genitourinary syndrome of menopause (GSM) is a symptomatic condition including vaginal dryness, irritation, dyspareunia and recurrent urinary tract infections which affects 40-54% of post-menopausal women. Although several estrogen-based therapies are available, it is generally preferable to avoid hormonal therapy, particularly in women with mild symptoms or at risk for estrogen-responsive neoplasia. Therefore, the most common treatment options are over-the-counter vaginal creams for symptomatic relief. METHODS Thirty-three postmenopausal women suffering from GSM were enrolled in this observational study. A multi-component cream (Ginetrox®, Indena, Milan, Italy) was applied on th…

medicine.medical_specialtyVisual analogue scaleVaginal DiseasesPainmedicine.disease_causeMedication AdherenceInternal medicinemedicineHumansAgedbusiness.industryGenitourinary systemObstetrics and GynecologySyndromeMiddle Agedmedicine.diseaseSymptomatic reliefMenopauseAdministration Intravaginalmedicine.anatomical_structureDyspareuniaTreatment OutcomeTolerabilityItalyVaginaVaginal Creams Foams and JelliesHormonal therapyFemalePlant PreparationsVulvar DiseasesIrritationMenopausebusinessMinerva ginecologica
researchProduct